Cargando…
Reversing the PAI-1-induced fibrotic immune exclusion of solid tumor by multivalent CXCR4 antagonistic nano-permeator
Fibrosis is one of the key factors that lead to the immune exclusion of solid tumors. Although degradation of fiber is a promising strategy, its application was still bottlenecked by the side effects of causing metastasis, resulting in the failure of immunotherapy. Here, we developed an antimetastat...
Autores principales: | Dong, Jingwen, Zhu, Chenfei, Huang, Ying, Li, Quanhao, Li, Jing, Wang, Zheng, Wang, Yixin, Zhou, Zhanwei, Sun, Minjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372828/ https://www.ncbi.nlm.nih.gov/pubmed/37521859 http://dx.doi.org/10.1016/j.apsb.2022.12.012 |
Ejemplares similares
-
Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy
por: Zhao, Ruogang, et al.
Publicado: (2022) -
A Bio‐Liposome Activating Natural Killer Cell by Illuminating Tumor Homogenization Antigen Properties
por: Yang, Xue, et al.
Publicado: (2023) -
Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy
por: Li, Zhaoting, et al.
Publicado: (2020) -
Gas permeation through rubbery polymer nano-corrugated membranes
por: Firpo, Giuseppe, et al.
Publicado: (2018) -
CXCR4 antagonists for treatment of breast cancer
por: Cortés, Javier, et al.
Publicado: (2018)